Janus Global Life Sciences Fund Class T (JAGLX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.


1 month+2.12% 3 years+37.26%
3 months+12.17% 5 years+26.92%
1 year+42.64% Since inception+13.07%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+26.92%+21.57%
Expense ratio0.93%1.45%
Risk 5 year sharpe ratio1.811.52
Net assets$4.0B$3.7B
Average market cap$16.9B$32.9B
Average P/E28.626.3
Portfolio turnover52%52%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyJanus
Fund manager & tenureAndrew Acker / 7 Years
Minimal initial investment$2,500.00
Minimum IRA investment--


U.S. stock72.21%
International stock23.43%
Fixed income1.64%
Top 5 Sectors
Portfolio weighting
Healthcare 94.74%
Consumer service 3.23%
Consumer goods 0.79%
Business service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson2.98%
BIIB Biogen2.72%
AMGN Amgen2.56%
-- 2.30%
CELG Celgene2.28%
AET Aetna2.14%
PCYC Pharmacyclics Inc2.14%
MNK Mallinckrodt Plc2.05%
-- 2.05%
HCA HCA Holdings Inc1.90%

To view my watchlist

Not a member yet?

Sign up now for a free account